News

PRESS MENTIONS
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
15 Jan 2025
Read More
Owlstone Medical Announces Investment of up to $2.3 Million USD from the Cystic Fibrosis Foundation to Develop a Breath Test for Pseudomonas aeruginosa Detection in Cystic Fibrosis Patients
Owlstone Medical Announces Investment of up to $2.3 Million USD from the Cystic Fibrosis Foundation to Develop a Breath Test for Pseudomonas aeruginosa Detection in Cystic Fibrosis Patients
Read More
25 Mar 2025
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
Read More
15 Jan 2025
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
Read More
30 Sep 2024
Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Read More
25 Apr 2024
Owlstone Medical Publishes Exciting Liver Data on the use of an EVOC® Probe for the Early Detection of Cirrhosis
Owlstone Medical Publishes Exciting Liver Data on the use of an EVOC® Probe for the Early Detection of Cirrhosis
Read More
9 Nov 2023
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
Read More
10 Oct 2023
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Tests for Liver Cirrhosis and NASH
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Tests for Liver Cirrhosis and NASH
Read More
22 Jun 2023
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Test for the Early Detection of Lung Cancer
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Test for the Early Detection of Lung Cancer
Read More
14 Jun 2023
Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health
Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health
Read More
4 Apr 2023
Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection
Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection
Read More
17 Mar 2023
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Read More
15 Mar 2023
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Read More
6 Feb 2023
1 2 3 4 5 … 8
Next

Talk to us about your biomarker research and how Breath Biopsy could help.

contact us